Tech Company Financing Transactions
Aleksey Funding Round
Third Rock Ventures and Pfizer Venture Investments invested in a $12 million Series A funding round for Aleksey. The financing round was announced on 6/2/2010.
Transaction Overview
Company Name
Announced On
6/2/2010
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Series A
Investors
Third Rock Ventures (Lead Investor) (Cary Pfeffer)
Pfizer Venture Investments (Barbara Dalton)
Proceeds Purpose
Proceeds from the financing will be used to continue advancing Ablexis' proprietary AlivaMab Mouse transgenic mouse platform for the discovery of human therapeutic antibodies.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
10581 Roselle St. 115
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Ablexis is a biotechnology company developing an innovative, next-generation platform for antibody drug discovery.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Larry Green
Browse more venture capital transactions:
Prev: 6/2/2010: Librato venture capital transaction
Next: 6/2/2010: Snapfinger venture capital transaction
Share this article
Where The Data Comes From
We record every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs